PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Oruka Therapeutics, Inc.
Filed: January 16, 2013
Period of Report: January 16, 2013
Accession Number: 0001193125-13-014886

View Document ↗ View on SEC.gov ↗